Zoetis
ZTS
#780
Rank
$32.42 B
Marketcap
$77.34
Share price
0.06%
Change (1 day)
-49.05%
Change (1 year)

P/E ratio for Zoetis (ZTS)

P/E ratio as of August 2026 (TTM): 12.8

According to Zoetis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 12.7897. At the end of 2025 the company had a P/E ratio of 20.9.

P/E ratio history for Zoetis from 2013 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202520.9-29.13%
202429.4-22.87%
202338.220.89%
202231.6-42.32%
202154.7
201940.246.29%
201827.5-28.74%
201738.627.08%
201630.4-53.58%
201565.491.36%
201434.215.63%
201329.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Pfizer
PFE
19.0 48.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
39.6 209.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
16.7 30.68%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
35.6 178.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Phibro Animal Health
PAHC
15.5 21.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-62.2-586.10%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.